Embed Size (px)
EJC SupplementsEditor-in-Chief: Alexander M.M. Eggermont
Institut Gustave RoussyVillejuif, France
Editors:
Basic and Preclinical Research: Richard Marais, Manchester, UKGiorgio Parmiani, Milan, Italy
Drug Development: Jean-Charles Soria, Villejuif, France
Early Breast Cancer: Kathleen I. Pritchard, Toronto, Canada
Advanced Breast Cancer: David Cameron, Edinburgh, UK
Gastrointestinal Cancers: Eric Van Cutsem, Leuven, BelgiumMichel Ducreux, Villejuif, France
Genitourinary Cancers: Cora Sternberg, Rome, Italy
Lung Cancer: Mary O’Brien, London, UK
Gynaecological Cancers: Ignace Vergote, Leuven, Belgium
Head and Neck Cancer: Kevin Harrington, London, UK
Sarcomas: Jean-Yves Blay, Lyon, France
Melanoma: Dirk Schadendorf, Essen, Germany
Neuro-oncology: Roger Stupp, Zurich, Switzerland
Epidemiology and Prevention: Jan Willem Coebergh, Rotterdam, The Netherlands
Paediatric Oncology: Rob Pieters, Rotterdam, The Netherlands
Founding Editor: Henri Tagnon
Past Editors: Michael Peckham, London, UK; Hans-Jorg Senn, St Gallen, Switzerland; John Smyth, Edinburgh, UK
Editorial Office: Elsevier, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK
Tel: +44 (0) 1865 843590, Email: [email protected]
EDITORIAL BOARD
BASIC, PRECLINICAL AND TRANSLATIONAL RESEARCH
A. Albini (Italy)P. Allavena (Italy)F. Balkwill (UK)M. Barbacid (Spain)M. Broggini (Italy)C. Catapano (Switzerland)J. Collard (The Netherlands)E. Garattini (Italy)
A. Gescher (UK)R. Giavazzi (Italy)I. Hart (UK)W. Keith (UK)L.A. Kiemeney (The Netherlands)J. Lunec (UK)D.R. Newell (UK)G.J. Peters (The Netherlands)
A. Puisieux (France)V. Rotter (Israel)M. Schmitt (Germany)C.G.J. Sweep (The Netherlands)G. Taraboletti (Italy)P. Vineis (UK)N. Zaffaroni (Italy)
EPIDEMIOLOGY AND PREVENTION
B. Armstrong (Australia)P. Autier (France)J.M. Borras (Spain)C. Bosetti (Italy)J. Faivre (France)S. Franceschi (France)D. Forman (France)
A. Green (Australia)K. Hemminki (Germany)C. Johansen (Denmark)L.A. Kiemeney (The Netherlands)M. Maynadie (France)H. Møller (UK)P. Peeters (The Netherlands)
S. Sanjose (Spain)M.K. Schmidt (The Netherlands)H. Storm (Denmark)L.V. van de Poll-Franse (The Netherlands)H.M. Verkooijen (The Netherlands)R. Zanetti (Italy)
PAEDIATRIC ONCOLOGY
C. Bergeron (France)A. Biondi (Italy)E. Bouffet (Canada)M. Cairo (USA)H. Caron (The Netherlands)
G. Chantada (Argentina)F. Doz (France)A. Ferrari (Italy)M.A. Grootenhuis (The Netherlands)K. Pritchard-Jones (UK)
L. Sung (Canada)M. van den Heuvel-Eibrink (The Netherlands)M. van Noesel (The Netherlands)
CLINICAL ONCOLOGY
J.-P. Armand (France)A. Ayhan (Japan)R. Blamey (UK)M. Bolla (France)J. Boyages (Australia)N. Brunner (Denmark)F. Cardoso (Portugal)J. Cassidy (UK)M. Castiglione (Switzerland)L. Cataliotti (Italy)L. Cheng (USA)H. Cody (USA)R. Coleman (UK)A. Costa (Italy)J. De Bono (UK)M.J.A. De Jong (The Netherlands)E. de Vries (The Netherlands)A. Dicker (USA)R. Dummer (Switzerland)F. Eisinger (France)S. Erridge (UK)
G. Ferrandina (Italy)H. Gabra (UK)H. Gelderblom (The Netherlands)B. Hasan (Belgium)J.C. Horiot (Switzerland)C. Huber (Germany)R. Jakesz (Austria)J. Jassem (Poland)D. Jodrell (UK)V.C. Jordan (USA)A. Katz (Brazil)M. Kaufmann (Germany)I. Kunkler (UK)L. Lindner (Germany)P.E. Lønning (Norway)P. Lorigan (UK)K. McDonald (Australia)R. Mertelsmann (UK)F. Meunier (Belgium)T. Mok (Hong Kong)D. Nam (Korea)
P. O’Dwyer (USA)J. Overgaard (Denmark)N. Pavlidis (Greece)J. Perry (Canada)P. Price (UK)D. Raghavan (USA)J. Ringash (Canada)J. Robert (France)A. Rody (Germany)D. Sargent (USA)M. Schmidinger (Austria)S. Sleijfer (The Netherlands)P. Sonneveld (The Netherlands)A. Sparreboom (USA)M. van den Bent (The Netherlands)M. Van Glabbeke (Belgium)G. Velikova (UK)U. Veronesi (Italy)A. Vincent-Salomon (France)A. Voogd (The Netherlands)E. Winquist (Canada)
